Great Basin Scientific (GBSN) : During the past 4 weeks, traders have been relatively bearish on Great Basin Scientific (GBSN), hence the stock is down -38.7% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -9.81% relative to the S&P 500. The 4-week change in the price of the stock is -36.02% and the stock has fallen -8.46% in the past 1 week. The stock has recorded a 20-day Moving Average of 26.99% and the 50-Day Moving Average is 38.94%.
Great Basin Scientific (NASDAQ:GBSN): The stock opened at $1.33 on Friday but the bulls could not build on the opening and the stock topped out at $1.34 for the day. The stock traded down to $1.05 during the day, due to lack of any buying support eventually closed down at $1.19 with a loss of -17.93% for the day. The stock had closed at $1.45 on the previous day. The total traded volume was 3,056,856 shares.
The company Insiders own 1.7% of Great Basin Scientific shares according to the proxy statements. Institutional Investors own 1.06% of Great Basin Scientific shares. In a related news, The Securities and Exchange Commission has divulged in a Form 4 filing that the director of Great Basin Scientific, Inc., Spafford David had purchased shares worth of $9,798 in a transaction dated on August 21, 2015. A total of 6,665 shares were purchased at a price of $1.47 per share. The information is based on open market trades at the market prices.Option exercises are not covered.
Great Basin Scientific, Inc. is a molecular diagnostic testing company. The Company is focused on the development and commercialization of its molecular diagnostic platform designed to test for infectious disease. The Company has a commercially available test, a diagnostic test for clostridium difficile (C. diff), which received clearance from the Food and Drug Administration (FDA). The Companys products under development also include a diagnostic test for Group B Strep., Staphylococcus Identification and Resistance Blood Infection Panel (Staph ID/R panel), STEC Test, Staph aureus (SA) Pre-Surgical Nasal Screen Test, Food Borne Pathogens Panel and Candida Blood Infection Panel. The Companys platform is an automated molecular diagnostic system, consisting of an analyzer and associated diagnostic tests.